We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Roche Holdings Ltd AG (QX) | USOTC:RHHBY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.07 | -0.23% | 29.75 | 29.55 | 30.50 | 30.05 | 29.53 | 29.80 | 5,444,214 | 21:57:01 |
By Cristina Roca
Roche Holding AG (RO.EB) said Tuesday that Peter Voser is stepping down as member of the company's board of directors, and that it is making changes to its corporate executive committee.
The Swiss pharmaceuticals company said Mr. Voser will step down at the end of June due to his role as interim chief executive of ABB Ltd. (ABBN.EB).
Roche also said Michael Heuer, chief executive of its Roche Diagnostics unit and a member of the executive committee, is retiring at the end of July. Roche named Thomas Schinecker his successor as of August 1.
Stephan Feldhaus, head of communications and a member of Roche's enlarged executive committee, is leaving the company at the end of September, Roche said. Roche named Barbara Schaedler as his successor effective October 1.
Separately on Tuesday, Germany's E.ON SE (EOAN.XE) said that Ms. Schaedler is leaving her post as executive vice president for communications at the company.
Write to Cristina Roca at cristina.roca@dowjones.com; @_cristinaroca
(END) Dow Jones Newswires
June 11, 2019 01:36 ET (05:36 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Roche (QX) Chart |
1 Month Roche (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions